Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
A standard 1 mg semaglutide pen typically delivers four individual injections on a weekly schedule, with each dose gradually increasing to help your body adjust. Understanding how your medication is structured helps you manage your weight loss journey effectively while tracking your progress toward health goals.
How Many Doses Are in a 1 mg Semaglutide Pen?
A 1 mg semaglutide pen is designed to deliver a stepped dosing protocol over approximately four weeks. Each pre-filled pen contains enough medication for four weekly injections, starting at 0.25 mg and increasing by 0.25 mg increments. This gradual titration approach allows your body to tolerate the medication while minimizing gastrointestinal side effects that can occur with rapid dose escalation.
The pen mechanism includes click-doses that deliver precise amounts, removing the need for manual measurement or calculation. Each click represents one week's dose, making the administration straightforward for patients managing their treatment at home. After completing the four-week cycle, most people transition to a maintenance dose or continue advancing based on their individual response and healthcare provider guidance.
The Semaglutide Dosing Escalation Schedule
Week one of semaglutide therapy begins with a 0.25 mg injection to assess tolerance and establish baseline side effect profiles. Week two increases to 0.5 mg, week three to 0.75 mg, and week four reaches 1.0 mg. This escalation pattern is called titration and mirrors clinical trial protocols that demonstrated optimal outcomes for weight reduction and metabolic improvements.
Some patients maintain 1.0 mg as their therapeutic dose, while others benefit from advancing to higher doses under medical supervision. PlexusDx works with qualified practitioners who evaluate individual metabolic responses, appetite suppression effectiveness, and safety markers before recommending dose adjustments. Your dose may need to go up. Your price won't—PlexusDx maintains flat monthly pricing regardless of dosing level, ensuring transparent and predictable costs throughout your treatment journey.
Beyond Standard Pens: Compounded Semaglutide Advantages
PlexusDx sources semaglutide from licensed 503A compounding pharmacies, which offer flexibility that pre-filled pens cannot match. Compounded formulations allow practitioners to tailor doses specifically to your needs, metabolism, and genetic response patterns. Unlike mass-manufactured pens with fixed increments, compounded injections can be adjusted in smaller or larger steps based on your clinical progress and tolerance profile.
Compounded semaglutide from PlexusDx begins at $149 per month and includes access to licensed 503A pharmacy standards, quality assurance protocols, and personalized dosing guidance. All medications are shipped directly to you across all 50 states without requiring insurance or membership fees. The Precision Peptide Genetic Test ($99 add-on after your first month) identifies your genetic predispositions across GLP1R, GIPR, FTO, and MC4R pathways, helping your provider optimize your specific therapeutic approach.
Managing Your Semaglutide Treatment and Monitoring Progress
Effective semaglutide therapy requires consistent weekly injections on the same day and time to maintain stable hormone levels and appetite control. Most people inject subcutaneously in the abdomen, thigh, or upper arm—rotated weekly to prevent lipodystrophy or tissue changes. Your provider will schedule follow-up assessments to evaluate weight loss velocity, metabolic markers, and any side effects that might warrant dose modification or supportive interventions.
PlexusDx patients receive ongoing clinical support to track their response throughout treatment. Documentation of weekly progress, tolerance changes, and therapeutic outcomes helps inform whether advancing your dose or maintaining your current level aligns with your weight loss objectives. Many patients experience significant benefits at lower doses combined with lifestyle modifications, while others require higher therapeutic levels to achieve their health targets.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long does one 1 mg semaglutide pen last?
A 1 mg semaglutide pen contains four weekly doses and typically lasts approximately 28 days when following the standard titration schedule. After completing the initial four-week escalation, you'll transition to your maintenance dose or continue advancing based on your provider's assessment and your individual metabolic response.
What clinical evidence supports semaglutide's weight loss effectiveness?
Randomized controlled trials including STEP 1 and STEP 2 demonstrated that semaglutide-treated patients achieved 15–17% body weight reductions over 68 weeks compared to 2–3% with placebo. GLP-1 receptor agonists work by enhancing satiety signals, slowing gastric emptying, and improving metabolic regulation through multiple physiological pathways.
How does PlexusDx pricing work compared to standard semaglutide prescriptions?
PlexusDx compounded semaglutide injections start at $149 per month with flat pricing across all dose levels—your dose may increase but your cost remains stable. No insurance, membership fees, or HSA/FSA restrictions apply, and medications ship directly to all 50 states for maximum accessibility.
What are common side effects during semaglutide dose escalation?
Nausea, vomiting, and mild gastrointestinal symptoms occur in 20–40% of patients during initial weeks, typically resolving as your body adjusts. Slower eating, adequate hydration, smaller meals, and ginger supplementation help manage these effects. Persistent or severe side effects warrant discussion with your provider about dose adjustments or temporary stabilization strategies.
How can the Precision Peptide Genetic Test personalize my semaglutide therapy?
PlexusDx's Precision Peptide Genetic Test analyzes 14 peptide pathways including GLP1R rs6923761 and GIPR rs1800437 variants that influence your individual semaglutide response. Understanding your genetic predispositions helps your provider select optimal dosing strategies and predict which patients benefit most from combination therapy versus monotherapy approaches.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Does Ozempic Start Working After Injection?
What is Comparable to Wegovy for Weight Loss?